Instituto Rosenbusch Valuation Multiples

Instituto Rosenbusch Overview

About Instituto Rosenbusch

Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.

Founded

1948

HQ

Employees

N/A

Website

rosenbusch.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $5M

EBITDA: ($2M)

EV

$6M

Valuation Multiples

Multiples.vc

Start free trial

Instituto Rosenbusch Financials

Instituto Rosenbusch reported last fiscal year revenue of $5M and negative EBITDA of ($2M).

In the same fiscal year, Instituto Rosenbusch generated ($433K) in gross profit, ($2M) in EBITDA losses, and had net loss of ($3M).

Instituto Rosenbusch P&L

In the most recent fiscal year, Instituto Rosenbusch reported revenue of $5M and EBITDA of ($2M).

Instituto Rosenbusch expects next 12-month revenue of XXX and NTM EBITDA of XXX

Instituto Rosenbusch Stock Performance

Instituto Rosenbusch has current market cap of $5M, and enterprise value of $6M.

Instituto Rosenbusch's stock price is $0.12.

Instituto Rosenbusch Valuation Multiples

Instituto Rosenbusch trades at 1.3x EV/Revenue multiple, and (3.2x) EV/EBITDA.

Instituto Rosenbusch Financial Valuation Multiples

As of April 11, 2026, Instituto Rosenbusch has market cap of $5M and EV of $6M.

Equity research analysts estimate Instituto Rosenbusch's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Instituto Rosenbusch has a P/E ratio of (1.6x).

Instituto Rosenbusch Margins & Growth Rates

Instituto Rosenbusch's revenue in the last fiscal year declined by (23%).

Instituto Rosenbusch Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Instituto Rosenbusch M&A Activity

Instituto Rosenbusch acquired XXX companies to date.

Last acquisition by Instituto Rosenbusch was on XXXXXXXX, XXXXX. Instituto Rosenbusch acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Instituto Rosenbusch Investment Activity

Instituto Rosenbusch invested in XXX companies to date.

Instituto Rosenbusch made its latest investment on XXXXXXXX, XXXXX. Instituto Rosenbusch invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).